Subscribe free

Sarcoma & rare tumors ·

Game-Changing Prognostic Models Unveiled for Gastrointestinal Melanoma

In a data-driven investigation involving 991 primary gastrointestinal melanoma patients, researchers constructed reliable prognostic models for predicting overall survival (OS) and cancer-specific survival (CSS). These models incorporated key factors like age, disease stage, lymph node density, and surgery. Rigorous testing confirmed their effectiveness, making them valuable tools for assessing the prognosis of primary gastrointestinal melanoma patients. This study empowers clinicians with enhanced predictive capabilities for these specific cases, potentially improving patient care and decision-making.

Journal Article by Zeng J, Zhu L (…) Yang Y et 2 al. in BMJ Open

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

open it in PubMed

Summaries are written to help you decide what to read. They do not replace the full paper.

Free · 5 minutes a day

Get every new paper in Sarcoma & rare tumors.

Plus the Daily Selection: the five most relevant papers of the day, each cut to its key points.

Specialty newsletters: every new paper in your field, as a list of titles linked to the source. Daily Selection: the five that matter, cut to their key points.

FreeNo spamOne-click unsubscribe

More in Sarcoma & rare tumors

The latest stitches

Ann Surg Oncol26 Oct 2026

SSTR PET finds more distant disease in GEP-NETs

In this 24-year surgical cohort, SSTR PET identified bone and retroperitoneal nodal metastases more often than Octreoscan—findings that may matter for operative planning.

Ann Surg Oncol11 May 2026

Mapping Surgical Evidence for GEP-NETs

Surgical management of gastro-entero-pancreatic neuroendocrine tumors is inconsistent, highlighting the need for clearer guidelines.

All papers in Sarcoma & rare tumors →